Emerging glucose oxidase-delivering nanomedicines for enhanced tumor therapy

Kaiyue Song1, Jiang Ming2, Bailong Tao3

  • 1Jiangxi Provincial Key Laboratory of Organic Functional Molecules, Institute of Organic Chemistry, Jiangxi Science and Technology Normal University, Nanchang 330013, China.

Insights

Nanomedicines deliver glucose oxidase (GOD) to deplete tumor glucose, enhancing cancer therapy by starving malignant cells. This review summarizes recent advances in GOD-delivering nanomedicines for improved antitumor strategies.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Malignant tumors exhibit altered glucose metabolism.
  • Glucose oxidase (GOD) therapy depletes tumor glucose, inducing starvation.
  • Nanomedicines offer precise delivery of GOD for enhanced glucose modulation.

Purpose of the Study:

  • To comprehensively review nanomedicines delivering GOD for tumor therapy.
  • To discuss advances in GOD delivery, starvation therapy, and sensitized/multimodal antitumor strategies.
  • To explore challenges and future directions for GOD-delivering nanomedicines.

Main Methods:

  • Literature review of nanomedicine applications in glucose oxidase delivery.
  • Analysis of GOD-based starvation therapy and its integration with other cancer treatments.
  • Discussion of nanomedicine-mediated remodeling of the tumor microenvironment.

Main Results:

  • Nanomedicines enable targeted delivery of GOD, overcoming limitations of traditional therapies.
  • GOD-delivering nanomedicines enhance antitumor effects by modulating tumor glucose levels.
  • Integration of GOD nanomedicines with other modalities shows promise for multimodal cancer therapy.

Conclusions:

  • GOD-delivering nanomedicines represent a promising strategy for cancer therapy.
  • Further research is needed to address challenges and optimize therapeutic outcomes.
  • This field holds significant potential for advancing nanomedicine and cancer treatment.